UNC Health Medication Formulary
Add Formweb to your mobile device
System Formulary Update
Omalizumab (Xolair) 300 mg prefilled syringe
September 30, 2025
Situation
Omalizumab (Xolair) 300 mg prefilled syringes were approved for addition to the health system formulary at the System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Omalizumab (Xolair) 300 mg prefilled syringe
Assessment/Recommendation
Change effective: Tuesday, October 21
System P&T voted to include the following products on the UNC Health Medication Formulary:
- Omalizumab (Xolair) 300 mg prefilled syringe
Note: Stock of this formulary product may vary at individual entities